Introduction to drug designing and development:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Nova Science Publishers
[2014]
|
| Schriftenreihe: | Pharmacology-research, safety testing, and regulation series
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 |
| Beschreibung: | Description based on online resource; title from PDF title page (ebrary, viewed January 4, 2014) |
| Beschreibung: | 1 online resource (292 pages) illustrations |
| ISBN: | 9781629485713 1629485713 9781629485560 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043779838 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160920s2014 |||| o||u| ||||||eng d | ||
| 020 | |a 9781629485713 |c ebook |9 978-1-62948-571-3 | ||
| 020 | |a 1629485713 |c ebook |9 1-62948-571-3 | ||
| 020 | |a 9781629485560 |9 978-1-62948-556-0 | ||
| 035 | |a (ZDB-4-EBA)ocn868921927 | ||
| 035 | |a (OCoLC)868921927 | ||
| 035 | |a (DE-599)BVBBV043779838 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 615.1/9 |2 23 | |
| 245 | 1 | 0 | |a Introduction to drug designing and development |c Rajnish Kumar, Anju Sharma and Rajesh Kumar Tiwari, editors |
| 264 | 1 | |a New York |b Nova Science Publishers |c [2014] | |
| 264 | 4 | |c © 2014 | |
| 300 | |a 1 online resource (292 pages) |b illustrations | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pharmacology-research, safety testing, and regulation series | |
| 500 | |a Description based on online resource; title from PDF title page (ebrary, viewed January 4, 2014) | ||
| 505 | 8 | |a This book is useful to readers who are just beginning in the field of drug design and development. It starts with an introduction and some basic information about drugs. Pharmacokinetic and pharmacodynamic aspects are covered in the initial chapters. Systemic descriptions of pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion are explained in simple and easy language. This book demonstrates detailed concepts of lead molecules and their sources. In addition, drug target classification, identification and validation strategies, as well as the design and develop | |
| 505 | 8 | |a INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Acknowledgment; Contributors; Chapter 1 Drugs: Introduction and Definition; Abstract; Introduction; History; Basic Terminologies Related to Drugs; Drug Nomenclature; Adverse Effects of Drugs; Classification of Drugs; References; Chapter 2 Pharmacokinetics; Abstract; Introduction; ADME Properties; Rates of Reaction; Models Associated with Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; References | |
| 505 | 8 | |a Chapter 3 PharmacodynamicsAbstract; Drug Receptor Theory; Occupation Theory; Mechanism of Drug Action; References; Chapter 4 Plants As a Source of Lead Molecules; Abstract; 1. Introduction; 2. System of Medicines; 3. Plant Metabolites; 4. Classification of Secondary Metabolites; 5. Terpenoids; 6. Alkaloids; 7. Non-Protein Amino Acids (NPAA's); 8. Polyketides; 9. Polyacetylenes; Conclusion; References; Chapter 5 Animals As a Source of Lead Molecules; Abstract; Introduction; Terrestrial Animals as Drug Resource; Marine Organism as Drug Resource | |
| 505 | 8 | |a Impact of Indiscreet Animal Application for Medicinal PurposesFuture of Animals as Drug Resource; References; Chapter 6 Drug Targets and ValidationTechniques; Abstract; What Are Drug Targets?; Characteristics of Drug Targets; Classification of Drug Targets; Drug Target Identification; Direct Biochemical Methods; Genetic Interaction Methods; Computational Inference Methods; Drug Target Validation; References; Chapter 7 Screening of Drugs; Abstract; ADME Property; Virtual Screening; Methods of Virtual Screening; Conclusion; References; Chapter 8 Structure-Based Drug Designing; Abstract | |
| 505 | 8 | |a Methods that Analyze the Active SiteMethods That Dock Whole Molecule; Connection Methods; References; Chapter 9 Concepts of Combinatorial Library; Abstract; 1. Introduction; 2. Combinatorial Chemistry Approaches; 3. Library Requirements; 4. Experimental Techniques in Combinatorial Chemistry; 5. Screening of Combinatorial Libraries; References; Chapter 10 Quantitative Structure Activity Relationship; Abstract; 1. Introduction; 2. Molecular Structure and Molecular Properties; 3. QSAR Equations; 4. Molecular Descriptors; 5. Free Wilson Analysis; 6. QSAR Modeling; 7. Three Dimensional (3D) Qsar | |
| 505 | 8 | |a 8. Difference between Traditional QSAR and 3DQSARReferences; Chapter 11 Pharmacophore Modeling; Summary; History of Pharmacophore; Pharmacophore Based Drug Designing; Golden Rule of Six; Hip-Hop Theory; HypoGen Theory; Software/Tools for Pharmacophore modeling; References; Chapter 12 Drug Formulation and Dosage Forms; Abstract; Introduction; A Suitable Dosage Form -- Why?; Therapeutic Response and a Suitable Dosage Form; Salient Features of a Suitable Dosage Form; Challenges in Developing Suitable Dosage Form; Classification of Dosage Forms; References; Chapter 13 Drug Regulatory Affairs | |
| 650 | 4 | |a Drug design | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Drugs / Design |2 fast | |
| 650 | 4 | |a Drug Discovery | |
| 650 | 4 | |a Pharmaceutical Preparations / chemical synthesis | |
| 650 | 4 | |a Pharmaceutical Preparations | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Drugs |x Research |a Pharmaceutical chemistry | |
| 700 | 1 | |a Kumar, Rajnish |e Sonstige |4 oth | |
| 700 | 1 | |a Sharma, Anju |e Sonstige |4 oth | |
| 700 | 1 | |a Tiwari, Rajesh Kumar |e Sonstige |4 oth | |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029190898 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=672173 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=672173 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176609003962368 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043779838 |
| collection | ZDB-4-EBA |
| contents | This book is useful to readers who are just beginning in the field of drug design and development. It starts with an introduction and some basic information about drugs. Pharmacokinetic and pharmacodynamic aspects are covered in the initial chapters. Systemic descriptions of pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion are explained in simple and easy language. This book demonstrates detailed concepts of lead molecules and their sources. In addition, drug target classification, identification and validation strategies, as well as the design and develop INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Acknowledgment; Contributors; Chapter 1 Drugs: Introduction and Definition; Abstract; Introduction; History; Basic Terminologies Related to Drugs; Drug Nomenclature; Adverse Effects of Drugs; Classification of Drugs; References; Chapter 2 Pharmacokinetics; Abstract; Introduction; ADME Properties; Rates of Reaction; Models Associated with Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; References Chapter 3 PharmacodynamicsAbstract; Drug Receptor Theory; Occupation Theory; Mechanism of Drug Action; References; Chapter 4 Plants As a Source of Lead Molecules; Abstract; 1. Introduction; 2. System of Medicines; 3. Plant Metabolites; 4. Classification of Secondary Metabolites; 5. Terpenoids; 6. Alkaloids; 7. Non-Protein Amino Acids (NPAA's); 8. Polyketides; 9. Polyacetylenes; Conclusion; References; Chapter 5 Animals As a Source of Lead Molecules; Abstract; Introduction; Terrestrial Animals as Drug Resource; Marine Organism as Drug Resource Impact of Indiscreet Animal Application for Medicinal PurposesFuture of Animals as Drug Resource; References; Chapter 6 Drug Targets and ValidationTechniques; Abstract; What Are Drug Targets?; Characteristics of Drug Targets; Classification of Drug Targets; Drug Target Identification; Direct Biochemical Methods; Genetic Interaction Methods; Computational Inference Methods; Drug Target Validation; References; Chapter 7 Screening of Drugs; Abstract; ADME Property; Virtual Screening; Methods of Virtual Screening; Conclusion; References; Chapter 8 Structure-Based Drug Designing; Abstract Methods that Analyze the Active SiteMethods That Dock Whole Molecule; Connection Methods; References; Chapter 9 Concepts of Combinatorial Library; Abstract; 1. Introduction; 2. Combinatorial Chemistry Approaches; 3. Library Requirements; 4. Experimental Techniques in Combinatorial Chemistry; 5. Screening of Combinatorial Libraries; References; Chapter 10 Quantitative Structure Activity Relationship; Abstract; 1. Introduction; 2. Molecular Structure and Molecular Properties; 3. QSAR Equations; 4. Molecular Descriptors; 5. Free Wilson Analysis; 6. QSAR Modeling; 7. Three Dimensional (3D) Qsar 8. Difference between Traditional QSAR and 3DQSARReferences; Chapter 11 Pharmacophore Modeling; Summary; History of Pharmacophore; Pharmacophore Based Drug Designing; Golden Rule of Six; Hip-Hop Theory; HypoGen Theory; Software/Tools for Pharmacophore modeling; References; Chapter 12 Drug Formulation and Dosage Forms; Abstract; Introduction; A Suitable Dosage Form -- Why?; Therapeutic Response and a Suitable Dosage Form; Salient Features of a Suitable Dosage Form; Challenges in Developing Suitable Dosage Form; Classification of Dosage Forms; References; Chapter 13 Drug Regulatory Affairs |
| ctrlnum | (ZDB-4-EBA)ocn868921927 (OCoLC)868921927 (DE-599)BVBBV043779838 |
| dewey-full | 615.1/9 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1/9 |
| dewey-search | 615.1/9 |
| dewey-sort | 3615.1 19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05618nmm a2200577zc 4500</leader><controlfield tag="001">BV043779838</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160920s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781629485713</subfield><subfield code="c">ebook</subfield><subfield code="9">978-1-62948-571-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1629485713</subfield><subfield code="c">ebook</subfield><subfield code="9">1-62948-571-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781629485560</subfield><subfield code="9">978-1-62948-556-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBA)ocn868921927</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)868921927</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043779838</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1/9</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Introduction to drug designing and development</subfield><subfield code="c">Rajnish Kumar, Anju Sharma and Rajesh Kumar Tiwari, editors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science Publishers</subfield><subfield code="c">[2014]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (292 pages)</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacology-research, safety testing, and regulation series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (ebrary, viewed January 4, 2014)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">This book is useful to readers who are just beginning in the field of drug design and development. It starts with an introduction and some basic information about drugs. Pharmacokinetic and pharmacodynamic aspects are covered in the initial chapters. Systemic descriptions of pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion are explained in simple and easy language. This book demonstrates detailed concepts of lead molecules and their sources. In addition, drug target classification, identification and validation strategies, as well as the design and develop</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Acknowledgment; Contributors; Chapter 1 Drugs: Introduction and Definition; Abstract; Introduction; History; Basic Terminologies Related to Drugs; Drug Nomenclature; Adverse Effects of Drugs; Classification of Drugs; References; Chapter 2 Pharmacokinetics; Abstract; Introduction; ADME Properties; Rates of Reaction; Models Associated with Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; References</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 3 PharmacodynamicsAbstract; Drug Receptor Theory; Occupation Theory; Mechanism of Drug Action; References; Chapter 4 Plants As a Source of Lead Molecules; Abstract; 1. Introduction; 2. System of Medicines; 3. Plant Metabolites; 4. Classification of Secondary Metabolites; 5. Terpenoids; 6. Alkaloids; 7. Non-Protein Amino Acids (NPAA's); 8. Polyketides; 9. Polyacetylenes; Conclusion; References; Chapter 5 Animals As a Source of Lead Molecules; Abstract; Introduction; Terrestrial Animals as Drug Resource; Marine Organism as Drug Resource</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Impact of Indiscreet Animal Application for Medicinal PurposesFuture of Animals as Drug Resource; References; Chapter 6 Drug Targets and ValidationTechniques; Abstract; What Are Drug Targets?; Characteristics of Drug Targets; Classification of Drug Targets; Drug Target Identification; Direct Biochemical Methods; Genetic Interaction Methods; Computational Inference Methods; Drug Target Validation; References; Chapter 7 Screening of Drugs; Abstract; ADME Property; Virtual Screening; Methods of Virtual Screening; Conclusion; References; Chapter 8 Structure-Based Drug Designing; Abstract</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Methods that Analyze the Active SiteMethods That Dock Whole Molecule; Connection Methods; References; Chapter 9 Concepts of Combinatorial Library; Abstract; 1. Introduction; 2. Combinatorial Chemistry Approaches; 3. Library Requirements; 4. Experimental Techniques in Combinatorial Chemistry; 5. Screening of Combinatorial Libraries; References; Chapter 10 Quantitative Structure Activity Relationship; Abstract; 1. Introduction; 2. Molecular Structure and Molecular Properties; 3. QSAR Equations; 4. Molecular Descriptors; 5. Free Wilson Analysis; 6. QSAR Modeling; 7. Three Dimensional (3D) Qsar</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">8. Difference between Traditional QSAR and 3DQSARReferences; Chapter 11 Pharmacophore Modeling; Summary; History of Pharmacophore; Pharmacophore Based Drug Designing; Golden Rule of Six; Hip-Hop Theory; HypoGen Theory; Software/Tools for Pharmacophore modeling; References; Chapter 12 Drug Formulation and Dosage Forms; Abstract; Introduction; A Suitable Dosage Form -- Why?; Therapeutic Response and a Suitable Dosage Form; Salient Features of a Suitable Dosage Form; Challenges in Developing Suitable Dosage Form; Classification of Dosage Forms; References; Chapter 13 Drug Regulatory Affairs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug design</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Design</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations / chemical synthesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="a">Pharmaceutical chemistry</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Rajnish</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharma, Anju</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tiwari, Rajesh Kumar</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029190898</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=672173</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=672173</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043779838 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:34:54Z |
| institution | BVB |
| isbn | 9781629485713 1629485713 9781629485560 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029190898 |
| oclc_num | 868921927 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 online resource (292 pages) illustrations |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Nova Science Publishers |
| record_format | marc |
| series2 | Pharmacology-research, safety testing, and regulation series |
| spelling | Introduction to drug designing and development Rajnish Kumar, Anju Sharma and Rajesh Kumar Tiwari, editors New York Nova Science Publishers [2014] © 2014 1 online resource (292 pages) illustrations txt rdacontent c rdamedia cr rdacarrier Pharmacology-research, safety testing, and regulation series Description based on online resource; title from PDF title page (ebrary, viewed January 4, 2014) This book is useful to readers who are just beginning in the field of drug design and development. It starts with an introduction and some basic information about drugs. Pharmacokinetic and pharmacodynamic aspects are covered in the initial chapters. Systemic descriptions of pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion are explained in simple and easy language. This book demonstrates detailed concepts of lead molecules and their sources. In addition, drug target classification, identification and validation strategies, as well as the design and develop INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Acknowledgment; Contributors; Chapter 1 Drugs: Introduction and Definition; Abstract; Introduction; History; Basic Terminologies Related to Drugs; Drug Nomenclature; Adverse Effects of Drugs; Classification of Drugs; References; Chapter 2 Pharmacokinetics; Abstract; Introduction; ADME Properties; Rates of Reaction; Models Associated with Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; References Chapter 3 PharmacodynamicsAbstract; Drug Receptor Theory; Occupation Theory; Mechanism of Drug Action; References; Chapter 4 Plants As a Source of Lead Molecules; Abstract; 1. Introduction; 2. System of Medicines; 3. Plant Metabolites; 4. Classification of Secondary Metabolites; 5. Terpenoids; 6. Alkaloids; 7. Non-Protein Amino Acids (NPAA's); 8. Polyketides; 9. Polyacetylenes; Conclusion; References; Chapter 5 Animals As a Source of Lead Molecules; Abstract; Introduction; Terrestrial Animals as Drug Resource; Marine Organism as Drug Resource Impact of Indiscreet Animal Application for Medicinal PurposesFuture of Animals as Drug Resource; References; Chapter 6 Drug Targets and ValidationTechniques; Abstract; What Are Drug Targets?; Characteristics of Drug Targets; Classification of Drug Targets; Drug Target Identification; Direct Biochemical Methods; Genetic Interaction Methods; Computational Inference Methods; Drug Target Validation; References; Chapter 7 Screening of Drugs; Abstract; ADME Property; Virtual Screening; Methods of Virtual Screening; Conclusion; References; Chapter 8 Structure-Based Drug Designing; Abstract Methods that Analyze the Active SiteMethods That Dock Whole Molecule; Connection Methods; References; Chapter 9 Concepts of Combinatorial Library; Abstract; 1. Introduction; 2. Combinatorial Chemistry Approaches; 3. Library Requirements; 4. Experimental Techniques in Combinatorial Chemistry; 5. Screening of Combinatorial Libraries; References; Chapter 10 Quantitative Structure Activity Relationship; Abstract; 1. Introduction; 2. Molecular Structure and Molecular Properties; 3. QSAR Equations; 4. Molecular Descriptors; 5. Free Wilson Analysis; 6. QSAR Modeling; 7. Three Dimensional (3D) Qsar 8. Difference between Traditional QSAR and 3DQSARReferences; Chapter 11 Pharmacophore Modeling; Summary; History of Pharmacophore; Pharmacophore Based Drug Designing; Golden Rule of Six; Hip-Hop Theory; HypoGen Theory; Software/Tools for Pharmacophore modeling; References; Chapter 12 Drug Formulation and Dosage Forms; Abstract; Introduction; A Suitable Dosage Form -- Why?; Therapeutic Response and a Suitable Dosage Form; Salient Features of a Suitable Dosage Form; Challenges in Developing Suitable Dosage Form; Classification of Dosage Forms; References; Chapter 13 Drug Regulatory Affairs Drug design MEDICAL / Pharmacology bisacsh Drug development fast Drugs / Design fast Drug Discovery Pharmaceutical Preparations / chemical synthesis Pharmaceutical Preparations Medizin Drugs Research Pharmaceutical chemistry Kumar, Rajnish Sonstige oth Sharma, Anju Sonstige oth Tiwari, Rajesh Kumar Sonstige oth |
| spellingShingle | Introduction to drug designing and development This book is useful to readers who are just beginning in the field of drug design and development. It starts with an introduction and some basic information about drugs. Pharmacokinetic and pharmacodynamic aspects are covered in the initial chapters. Systemic descriptions of pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion are explained in simple and easy language. This book demonstrates detailed concepts of lead molecules and their sources. In addition, drug target classification, identification and validation strategies, as well as the design and develop INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; INTRODUCTION TO DRUG DESIGNING AND DEVELOPMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Acknowledgment; Contributors; Chapter 1 Drugs: Introduction and Definition; Abstract; Introduction; History; Basic Terminologies Related to Drugs; Drug Nomenclature; Adverse Effects of Drugs; Classification of Drugs; References; Chapter 2 Pharmacokinetics; Abstract; Introduction; ADME Properties; Rates of Reaction; Models Associated with Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; References Chapter 3 PharmacodynamicsAbstract; Drug Receptor Theory; Occupation Theory; Mechanism of Drug Action; References; Chapter 4 Plants As a Source of Lead Molecules; Abstract; 1. Introduction; 2. System of Medicines; 3. Plant Metabolites; 4. Classification of Secondary Metabolites; 5. Terpenoids; 6. Alkaloids; 7. Non-Protein Amino Acids (NPAA's); 8. Polyketides; 9. Polyacetylenes; Conclusion; References; Chapter 5 Animals As a Source of Lead Molecules; Abstract; Introduction; Terrestrial Animals as Drug Resource; Marine Organism as Drug Resource Impact of Indiscreet Animal Application for Medicinal PurposesFuture of Animals as Drug Resource; References; Chapter 6 Drug Targets and ValidationTechniques; Abstract; What Are Drug Targets?; Characteristics of Drug Targets; Classification of Drug Targets; Drug Target Identification; Direct Biochemical Methods; Genetic Interaction Methods; Computational Inference Methods; Drug Target Validation; References; Chapter 7 Screening of Drugs; Abstract; ADME Property; Virtual Screening; Methods of Virtual Screening; Conclusion; References; Chapter 8 Structure-Based Drug Designing; Abstract Methods that Analyze the Active SiteMethods That Dock Whole Molecule; Connection Methods; References; Chapter 9 Concepts of Combinatorial Library; Abstract; 1. Introduction; 2. Combinatorial Chemistry Approaches; 3. Library Requirements; 4. Experimental Techniques in Combinatorial Chemistry; 5. Screening of Combinatorial Libraries; References; Chapter 10 Quantitative Structure Activity Relationship; Abstract; 1. Introduction; 2. Molecular Structure and Molecular Properties; 3. QSAR Equations; 4. Molecular Descriptors; 5. Free Wilson Analysis; 6. QSAR Modeling; 7. Three Dimensional (3D) Qsar 8. Difference between Traditional QSAR and 3DQSARReferences; Chapter 11 Pharmacophore Modeling; Summary; History of Pharmacophore; Pharmacophore Based Drug Designing; Golden Rule of Six; Hip-Hop Theory; HypoGen Theory; Software/Tools for Pharmacophore modeling; References; Chapter 12 Drug Formulation and Dosage Forms; Abstract; Introduction; A Suitable Dosage Form -- Why?; Therapeutic Response and a Suitable Dosage Form; Salient Features of a Suitable Dosage Form; Challenges in Developing Suitable Dosage Form; Classification of Dosage Forms; References; Chapter 13 Drug Regulatory Affairs Drug design MEDICAL / Pharmacology bisacsh Drug development fast Drugs / Design fast Drug Discovery Pharmaceutical Preparations / chemical synthesis Pharmaceutical Preparations Medizin Drugs Research Pharmaceutical chemistry |
| title | Introduction to drug designing and development |
| title_auth | Introduction to drug designing and development |
| title_exact_search | Introduction to drug designing and development |
| title_full | Introduction to drug designing and development Rajnish Kumar, Anju Sharma and Rajesh Kumar Tiwari, editors |
| title_fullStr | Introduction to drug designing and development Rajnish Kumar, Anju Sharma and Rajesh Kumar Tiwari, editors |
| title_full_unstemmed | Introduction to drug designing and development Rajnish Kumar, Anju Sharma and Rajesh Kumar Tiwari, editors |
| title_short | Introduction to drug designing and development |
| title_sort | introduction to drug designing and development |
| topic | Drug design MEDICAL / Pharmacology bisacsh Drug development fast Drugs / Design fast Drug Discovery Pharmaceutical Preparations / chemical synthesis Pharmaceutical Preparations Medizin Drugs Research Pharmaceutical chemistry |
| topic_facet | Drug design MEDICAL / Pharmacology Drug development Drugs / Design Drug Discovery Pharmaceutical Preparations / chemical synthesis Pharmaceutical Preparations Medizin Drugs Research Pharmaceutical chemistry |
| work_keys_str_mv | AT kumarrajnish introductiontodrugdesigninganddevelopment AT sharmaanju introductiontodrugdesigninganddevelopment AT tiwarirajeshkumar introductiontodrugdesigninganddevelopment |